EXPERMED 2026

In June, Istanbul became a meeting point for more than 300 fertility specialists from 19 countries as EXPERMED 2026 welcomed clinicians, embryologists, researchers and healthcare professionals for two days dedicated to the future of reproductive medicine.

Hosted by Bahçeci, one of FutureLife Group's leading fertility centres, the congress provided a platform for sharing the latest scientific knowledge, clinical experience and innovative approaches that continue to shape fertility treatment worldwide.

The programme covered a wide range of topics, including assisted reproduction, reproductive genetics, embryology, fertility preservation, artificial intelligence in IVF and personalised patient care. Through expert presentations and scientific discussions, participants explored the latest developments that are helping improve clinical practice and patient outcomes across the field of reproductive medicine.

Scientific congresses such as EXPERMED play an essential role in advancing fertility care. They encourage collaboration between healthcare professionals, researchers and innovators, creating opportunities to exchange ideas, discuss emerging research and explore new technologies that can benefit patients around the world.

At FutureLife Group, we believe that continuous education, international collaboration and knowledge sharing are fundamental to delivering the highest standards of fertility care. Supporting scientific events such as EXPERMED reflects our commitment to innovation and to translating scientific progress into everyday clinical practice.

We would like to thank Bahçeci for hosting this year's congress, as well as all speakers, participants and partners whose expertise and commitment made EXPERMED 2026 another inspiring milestone for the international fertility community.